PlainPharmaWatch

CMS Open Payments · Program Year 2024

Innova Vascular Inc.

Innova Vascular Inc. reported $57,089.71 in payments to 28 physicians and teaching hospitals across 30 transactions.

$57.1K
Total payments
30
Transactions
28
Recipients
#1321
of 1,925 companies

Innova Vascular Inc. reported $57,089.71 in payments to 28 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1321 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $2.0K per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

The verdict

Innova Vascular Inc. pairs below-median payment volume with a concentrated payment pattern focused on a handful of top recipients.

#1321
of 1,925 companies
0.0%
of all US industry payments
0.7%
paid to its single top recipient
3
payment categories

How Innova Vascular Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Innova Vascular Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$57,090 31st percentile higher than 31% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). This entry sits in this band. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Innova Vascular Inc.

Innova Vascular Inc. ranks #1321 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $57,089.71 across 30 transactions to 28 physicians and teaching hospitals - $1.9K per transaction and $2.0K per recipient on average.

5 transactions worth $7.6K make "Travel and Lodging" the top general-payment category in the 3-category breakdown below, 13.3% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Innova Vascular Inc. made 3 types of general payments. "Travel and Lodging" is the largest category at $7.6K, 13.3% of the company's reported total.

How Innova Vascular Inc. divides its payments

How the reported total splits across payment categories

1. Travel and Lodging$7.6K2. Food and Beverage$2.2K3. Consulting Fee$1.3K
Payment Type Amount Transactions
Travel and Lodging $7.6K 5
Food and Beverage $2.2K 21
Consulting Fee $1.3K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $9,643.17 (87.2%) of $11,053.71 in this company's General Payments records across 15 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Innova Vascular Inc.

The five named recipients with the highest reported General Payments from this company

Santhosh Mathews$7.6KBhavraj Khalsa$1.4KBashir Akhavan Tafti$290.00Kevin Burns$176.10William Keeling$159.87
  1. 1

    Santhosh Mathews

    $7,591.10 across 9 reported transactions

  2. 2

    Bhavraj Khalsa

    $1,426.10 across 3 reported transactions

  3. 3

    Bashir Akhavan Tafti

    $290.00 across 1 reported transactions

  4. 4

    Kevin Burns

    $176.10 across 1 reported transactions

  5. 5

    William Keeling

    $159.87 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.9K. Average per recipient: $2.0K.

Total Amount

$57,089.71

Avg per Transaction

$1.9K

Avg per Recipient

$2.0K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Innova Vascular Inc. Share

0.0%

#1321 by total payments

Frequently Asked Questions

How much did Innova Vascular Inc. pay to physicians and hospitals in 2024?
In Program Year 2024, CMS Open Payments recorded $57,089.71 from Innova Vascular Inc. to physicians and hospitals across 30 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Innova Vascular Inc.?
Averaging $2.0K per recipient, Innova Vascular Inc.'s 2024 payments reached 28 physicians and teaching hospitals.
What types of payments did Innova Vascular Inc. make?
3 categories of general payment make up Innova Vascular Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Travel and Lodging" at $7.6K, representing 13.3% of the company's reported total.
How does Innova Vascular Inc. rank among pharmaceutical companies?
Innova Vascular Inc. ranks #1321 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Innova Vascular Inc.?
Innova Vascular Inc.'s 30 transactions to 28 recipients in 2024 averaged $1.9K per transaction.
Where does the payment data for Innova Vascular Inc. come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Innova Vascular Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.